up home page bottom

French German version Spanish version Italian version

header image

Health and Human Services Reports 2009 H1N1Vaccine Development Activities

Since 2004, HHS has contracted with manufacturers that currently hold U.S. licenses for flu vaccine as part of the National Strategy for Pandemic Influenza. In May 2009, HHS issued new orders on these contracts to produce a bulk supply of vaccine antigen and adjuvant and to produce pilot (also called investigational) lots of a 2009 H1N1 vaccine.

Share

Flu Vaccine Fact Sheet

“By 1853, Parliament began passing laws to make the untested vaccine compulsory throughout the British Empire. Other countries of Europe followed suit. Once the economic implications of compulsory vaccinations were realized, few dared to
disagree. Then, as now, the media were controlled by the vaccine manufacturers and the government, who stood to make huge money from the sale of these spurious vaccines.”… Tim O’Shea, D.C.

Share

The U.S. House of Representatives Approves $8 Billion for Swine Flu (H1N1) Pandemic

The U.S. House of Representatives approved $7.65 billion in new money to respond to the swine flu pandemic. The money will go toward the purchase of vaccine, antiviral drugs, and other medical needs. Congress also stipulated that the funds be available for surveillance and to help assist international efforts. At least $350 million must be spent on “upgrading State and local capacity.”

Share

Commercial Manufacturing of H1N1 ‘Swine Flu’ Vaccine Underway

Protein Sciences Corporation (PSC) announced that today it commenced manufacturing of a vaccine to protect humans against the H1N1 “swine flu” virus. The Company estimates that it can produce 100,000 doses this week and at least 100,000 doses per week thereafter. The vaccine, called PanBlok(R), is made using PSC’s proprietary baculovirus and insect cell manufacturing technology. PSC believes that PanBlok is the first and only vaccine that could be used to protect against the escalating worldwide pandemic, at least for the next few months.

Share